Register for this Class   Bring Course On-Site

Course H300
Responding to FDA 483s & Warning Letters

---

Developing Consistent, Accurate Response - Avoiding Further Regulatory Action

This course will teach you to master:

• The FDA 483 Components
• Warning Letter Components
• FDA Internal Policies
• Off-Label Selling
• Interpreting FDA Expectations
• Responding to Specific Observations
• Providing Consistent Responses
• Working with General Council
• Challenging Agency Observations
• The Face to Face FDA Meeting
• The Common Response Pitfalls
• The SOP and Response Letter Template
  

With much at risk, know where you stand and what action is required.

In recent months, the volume of 483s and Warning Letters issued have increased dramatically. If you are the recipient of an FDA 483 or Warning Letter, it can be a challenging and lonely experience. You and your organization can be stopped dead in your tracks. This two-day program taught by one of the nation’s leading Compliance consultants will help give you the solid and reliable information you need to make the right moves and the right decisions.

This workshop will provide a unique opportunity to work with an expert in the field and others who face similar challenges. Together you'll develop forensics and information-gathering skills to address the issues required to respond to a warning letter. You'll also leave knowing how, if and when to best engage your legal representation, what questions to ask, and what you should expect from them. With so much at risk, ensure that you WILL know the processes and procedures that an FDA Warning Letter requires.

After attending, you and your team will know how to interpret the content of this FDA correspondence and know what path you need to take for the necessary response. In addition to general observations, you’ll learn how to respond to specific deficiencies such as product control or record management - as well as the full gamut of FDA-regulated procedures and all areas under FDA regulation.

Not just basics! You’ll learn specifically how to respond to observations that are across the organization

In addition to solid, no-nonsense instruction and advice, you’ll enjoy case studies that provide real-world reinforcement of all the issues you examine - from firms who have been there. You’ll also work with "mock" Warning Letters and 483’s to create your own responses which will thoroughly and accurately satisfy the FDA. Using an instructor-developed template, you’ll learn to create consistent responses that will continually be of important use over time. Specifically, you will address:

• Management Controls
• Off-Label Selling
• Product Testing
• Manufacturing/Production
• Advertising/Labeling
• Facility and Equipment
• Validation and Equipment Qualifications
• Auditing and Record Management
• Training and More

Know where you stand, what actions you need to take, who needs to be involved, and know how to develop the game plan for a thorough response.

Immediate Benefits of Participating In This Workshop

1. Learn from an expert in the field to confidently respond on all levels to FDA Warning letters
2. Create a common synergy in your organization, and common goals in preparing your response to the FDA
3. Give your management team knowledge of the process and procedures that an FDA Warning Letter requires
4. Learn from mistakes made by other firms in dealing with the FDA, hear the details and insights into what went wrong, and understand the processes and the responses that will work for you
5. Reduce risks of down time by interrupted development, distribution, production or sale of your product
6. Know the level of commitment required from your company resources to address FDA communications
7. Learn to understand the subtle and major differences between FDA Actions of a Warning Letter versus a 483
8. Interpret exactly what the FDA Agency will be expecting in a response from your company
9. Ensure consistency among responses in the future via a course-provided SOP and Template for responding to FDA correspondence
10. Learn how to challenge 483s and Warning Letters without fear of repercussions associated with challenging Agency findings
11. Avoid the common and major pitfalls and hasty responses to the FDA, ensuring quick conclusion
12. Confidently respond to product testing, advertising claims, facility and equipment issues
13. Immediately be able to take advantage of and integrate the Instructor-developed Response Template and SOP that will be a dependable tool in all of your decisions regarding FDA responses and response letters
14. Respond to Warnings on Auditing, Record Management, and Validation Issues
15. Learn from mistakes made by other firms in dealing with the FDA, hear the details and insights into what went wrong, understand the processes the and responses that will work for you
16. Become experienced and comfortable with interpreting FDA actions and understand how to respond on all levels within your organization and with the FDA
17. Avoid expensive ongoing litigation and major interruptions in product development and delivery
18. Know when it’s a smart option to request a face-to-face meeting with the FDA, and how to request a meeting
19. Know how to respond to warnings of Management, Manufacturing, Production and Control Deficiencies - and all areas influences by the FDA
20. Enjoy one-on-one consulting from your expert instructor, and get answers to your specific questions

---

Course Outline

I. Course Overview, Individual Objectives and Class Objectives
In this segment, professionals will be introduced to your instructor, your peers, make certain that we are in line to meet common learning objectives. You and your instructor will know what you need to accomplish and take away from this workshop.
   A. Course Overview
   B. Instructor Qualifications
   C. FDA Structure and Responsibilities

II. The FDA Form 483
Understand why and how FDA developed these communications and actions. Interpret what the agency is expecting in response from your organization.
   A. History and background of the FDA Form 483
   B. FDA’s Internal Procedures and Policies Associated with 483s
   C. What action is FDA really taking with your firm
   D. Legal Responsibilities and Required Action

III. The FDA Warning Letter
In this segment, participants will understand the subtle and more important differences between a Warning Letter and a 483. You’ll also cover changes in policy and procedures that are recently introduced.
   A. The History and Intent of Warning Letters
   B. FDA’s Internal Procedures and Policies Used In Warning Letters
   C. New 2009 Changes in Warning Letter Issuance Policy
   D. Legal responsibilities and Required Actions In Response
   E. Behind the scenes FDA Actions when initialing a Warning Letter
   F. Warning Letter vs. Form 483, the Differences

IV. Responding to 483s and Warning Letters - Avoid Further Actions
Receiving a Warning Letter or 483 can stop you and your firm right in your tracks. In this section, you will learn what response you should take based on the Warning content as well as be provided with an instructor-developed template to help you simplify the process.
   A. Planning a Response Letter
   B. Format and Content Options
   C Content in response to Observations
   D. Using a Response Template and SOP
   E. Determining When to Include Attachments
   F. Support Documentation (what to include)

V. Responding to Commonly Encountered Observations
In this section, participants will learn specific techniques and guidelines that can help you accurately and thoroughly respond to specific types of FDA Observations. You will be able to accurately assess the type of Warning and respond with the detail needed to satisfy the FDA.
   A. Management Controls Related Observations
   B. Product Testing Related Observations
   C. Manufacturing/Production Controls Related Observations
   D. Training Related Observation Response
   E. Advertising/Labeling and Promotional Claims
   F. Auditing Related Observations
   G. Facility and Equipment Related Observations
   H. Validation and Equipment Qualification Issues
   I. Record Management Related Observations

VI. Methods for Avoiding Further Action from the FDA
Workshop participants will be introduced to a variety of options that may help satisfy the FDA and help avoid further action. Students will learn how to comfortably and confidently work with the Agency. Learn to avoid continuous letter writing and legal fees.
   A. How to Challenge FDA’s Observations
      1. Determining method of challenge
      2. Avoiding FDA Agency Repercussions
   B. Face-to-face Meeting with FDA
      1. When to request a meeting
      2. How to request the meeting
      3. What to discuss
      4. Thwarting Potential Further Action
   C. Avoiding Commonly Encountered Pitfalls
      1. Preventative Action Items
      2. Creating Follow Through Plans
      3. Attorney Involvement Issues
      4. Documentation Issues

VII. In-Class Exercise
Create your own response to FDA Warnings in class - with instructor guidance. Students will be presented a specific examples of 483s and Warning Letters. Participants will respond using the methodologies taught in class. With in class instructor follow-up and review for adequacy and accuracy.

VIII. Case Studies - Real World: What Worked, What Did Not
Participants will be presented an example of a poorly executed response to a routine inspection that resulted in a never-ending poor relationship with the FDA. You’ll examine in detail, where mistakes where made and what alternative action could have made a major difference.

Workshop attendees will examine and dissect a perfect response to a potentially devastating inspection that ceased immediate sanctions or actions from the FDA.

IX. cGMP Training Credit
This course answers the FDA’s requirement for periodic cGMP training. Students will review material covered and make certain they are comfortable with what they have learned, skills taught and be able to implement them back at the worksite.
   A. Student Competency Assessment
   B. Documented Training Verification

Students may use AHSI training forms or their own in house training form to address the FDA’s requirement of periodic cGMP training.

X. One-on-One Student Assistance - Addressing Your Specific Issues
In this ending segment of the program, students will have extra time available with the Course Developer to discuss their own specific issues with Warning Letters or 483s. Whether you would like your issues discussed openly in group discussion or would prefer private time, you and your associates will take advantage of this private one-on-one consulting to answer your specific needs after the workshop has ended.

---

Who should attend

When a 483 or Warning Letter arrives it can be an alarming experience without the knowledge you need to handle the situation. Whether you are a Quality Manager or responsible on any level with an FDA controlled product, you should attend. Those who benefit most include:

• CEO’s
• Presidents
• Vice Presidents
• Managers on all levels of Quality, Regulatory Affairs, Sales and Scientific Affairs